Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.21 USD | +2.42% | -3.18% | +49.33% |
May. 13 | RxSight Raises $115 Million From Public Offering of Shares | MT |
May. 07 | Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating | MT |
Business Summary
Number of employees: 374
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Light Adjustable Lenses and Related Capital Equipment
100.0
%
| 49 | 100.0 % | 89 | 100.0 % | +81.77% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 49 | 100.0 % | 89 | 100.0 % | +81.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
Shelley Thunen
DFI | Director of Finance/CFO | 72 | 15-12-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Matt Haller
CTO | Chief Tech/Sci/R&D Officer | - | 13-04-30 |
Ilya Goldshleger
COO | Chief Operating Officer | 49 | 15-08-31 |
Chief Tech/Sci/R&D Officer | - | 00-02-29 | |
Comptroller/Controller/Auditor | - | - | |
Steve Everly
SAM | Sales & Marketing | - | 21-08-16 |
Caroline Vaughn
HRO | Human Resources Officer | - | 22-01-31 |
Roy Freeman
SAM | Sales & Marketing | - | 21-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Palmisano
BRD | Director/Board Member | 79 | 21-08-09 |
Bill Link
BRD | Director/Board Member | 78 | 16-10-31 |
Ronald Kurtz
CEO | Chief Executive Officer | 60 | 15-05-31 |
J. Corley
CHM | Chairman | 68 | 14-12-31 |
Juliet Bakker
BRD | Director/Board Member | 62 | 14-12-31 |
Julie Andrews
BRD | Director/Board Member | 52 | 21-08-09 |
Director/Board Member | 40 | 21-12-30 | |
Robert Warner
BRD | Director/Board Member | 57 | 21-08-09 |
Tamara Fountain
BRD | Director/Board Member | 61 | 21-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,947,467 | 36,967,720 ( 94.92 %) | 0 | 94.92 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.33% | 2.29B | |
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+2.33% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- RXST Stock
- Company RxSight, Inc.